Posts
News
NEWS
MAESTRIA Consortium Meeting, Paris: 8th and 9th May 2025
The MAESTRIA Consortium, which consists of 18 partners from different European countries, met for the…
EAST-STROKE Videointerview
Prof. Dr. med. Götz Thomalla (UKE) and Dr. med. Märit Jensen (UKE) have recorded a…
Prof. Dr. med. Thomas Meinertz
On behalf of all our members, we would like to congratulate our AFNET founding member…
ESC Congress 2024
AFNET associated events:
30th of August 2024, 10:27 am (CEST/German time) / 9:27 am (BST/British time):…
Heart Rhythm Congress 2024
16th of May 2024, 7:00 pm (CEST/German time) / 1:00 pm (EASTERN/Boston time): “160 – BCEC…
AFNET Image film
Explore our image film and see who’s behind AFNET.
Four researchers receive DGK AFNET Young Investigator Award for atrial fibrillation
At the annual meeting of the German Society of Cardiology (DGK), four scientists will be…
20 Years of AFNET-Booklet
We are pleased to present you our bookelt on the occasion of our 20th anniversary.
You…
ESC Congress 2023
ANET associated events:
25 August 2023, 8:30, “Stockholm”, Stroke and bleeding risk in atrial fibrillation: walking the tight rope…
PRESS RELEASES
Global consensus document on atrial cardiomyopathy published – AFNET scientists lead the way
An international cardiology working group has published a consensus report on atrial cardiomyopathy (1). 21…
Do patients with device-detected atrial fibrillation and prior stroke benefit from anticoagulation?
A subgroup analysis of the NOAH – AFNET 6 trial revealed: In patients with device-detected…
Circulating biomolecules identify patients with atrial fibrillation at high risk of cardiovascular events
An analysis of the biomolecule substudy of the EAST – AFNET 4 trial revealed: biomolecule…
Patients with device-detected atrial fibrillation and multiple comorbidities do not benefit from anticoagulation
In patients with device-detected atrial fibrillation and a high comorbidity burden, oral anticoagulation increases bleeding…
Longer and better lives for patients with atrial fibrillation – AFNET/EHRA expert panel published a position paper
An international panel of experts published recommendations to improve management of atrial fibrillation (AF). The…
AFNET trials provide key evidence for atrial fibrillation guideline recommendations
Investigator-initiated trials led by the German Atrial Fibrillation NETwork (AFNET) provide evidence for several recommendations…
Do long episodes of device-detected atrial fibrillation justify anticoagulation?
In patients with device-detected atrial fibrillation the risk of stroke appears low (1% per year)…
9th AFNET/EHRA Consensus Conference: International experts discuss ideas to improve management of atrial fibrillation
On 12 and 13 September international experts in atrial fibrillation come together in Münster, Germany,…
Patients with rare and short atrial arrhythmias do not benefit from anticoagulation
The clinical trial NOAH – AFNET 6 conducted by the German Atrial Fibrillation Network (AFNET),…